Precision Biosciences (DTIL) EPS (Basic) (2018 - 2026)
Precision Biosciences (DTIL) posted quarterly EPS (Basic) of -$0.35 for Q1 2026, up 84.8% year-over-year from -$0.19 in Q1 2025, and down 134.34% quarter-over-quarter from $1.01 in Q4 2025.
Precision Biosciences (DTIL) EPS (Basic) (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has reported EPS (Basic) for 9 consecutive years, with -$0.35 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 84.8% year-over-year to -$0.35; the TTM figure through Mar 2026 stood at -$1.84 (up 71.0% YoY), while the FY2025 annual figure was $0.07, changed N/A from the prior year.
- EPS (Basic) eased to -$0.35 in Q1 2026 per DTIL's latest filing, from $1.01 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.23 in Q2 2024 and bottomed at -$16.83 in Q1 2022.
- Historically, EPS (Basic) has averaged -$3.23 across 5 years, with a median of -$2.29 in 2025.
- On a YoY basis, EPS (Basic) climbed as much as 195.93% in 2024 and fell as far as 485.05% in 2024.
- Precision Biosciences' EPS (Basic) stood at -$3.09 in 2022, then jumped by 75.97% to -$0.74 in 2023, then sank by 370.11% to -$3.49 in 2024, then soared by 129.01% to $1.01 in 2025, then sank by 134.34% to -$0.35 in 2026.
- Business Quant data shows DTIL's EPS (Basic) at -$0.35 in Q1 2026, $1.01 in Q4 2025, and -$2.34 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | 0.18 |
| 10 | Precision Biosciences | 224.95 Mn | 137.40 Mn | - | -0.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.96 |
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | 1.01 |
| Sep 30, 2025 | -2.34 |
| Jun 30, 2025 | -2.01 |
| Mar 31, 2025 | -2.29 |
| Dec 31, 2024 | -3.49 |
| Sep 30, 2024 | -4.04 |
| Jun 30, 2024 | 2.23 |
| Mar 31, 2024 | -0.61 |
| Dec 31, 2023 | -0.74 |
| Sep 30, 2023 | 1.05 |
| Jun 30, 2023 | -2.33 |
| Mar 31, 2023 | -2.99 |
| Dec 31, 2022 | -3.09 |
| Sep 30, 2022 | -2.23 |
| Jun 30, 2022 | -15.83 |
| Mar 31, 2022 | -16.83 |
| Dec 31, 2021 | -15.70 |
| Sep 30, 2021 | -11.13 |